“…Five studies reported AJCC cancer stages for black patients, with weighted mean % of patients at stage I ( n = 501 patients, 52.6%) , stage II ( n = 223, 24.1%), stage III ( n = 123, 16.3%), and stage IV ( n = 101, 13.2%). 4 , 6 , 15 , 19 , 33 Seven studies comparing non-Hispanic white and black survival reported histological subtype stratified by race, with total patients and mean proportion of patients as follows: nodular melanoma (black: n = 1090, 10.0%; non-Hispanic white: n = 72029, 9.1%), lentigo maligna melanoma ( n = 196, 3.7%; n = 75631, 7.6%), superficial spreading melanoma ( n = 1611, 19.0%; n = 312754, 39.3%), and acral lentiginous melanoma ( n = 2107, 19.4%; n = 8141, 0.99%). 2 , 4 , 6 , 18 , 23 , 34 , 45 The most common subtype reported in black patients were superficial spreading melanoma in 4 studies, and acral lentiginous melanoma in 3 studies, while superficial spreading melanoma was the most commonly reported subtype for non-Hispanic white patients among all 7 studies.…”